A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to evaluate safety and tolerability of a single
application of Ha44 Gel 0.74% w/w for the treatment of head lice. Secondary purpose is to
evaluate PK of Ha44 and benzyl alcohol under conditions of maximal exposure in pediatric
population.
Phase:
Phase 2
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited Hatchtech Pty Ltd